Skip to main content
Premium Trial:

Request an Annual Quote

More Cuts

AstraZeneca will be cutting 8,000 jobs over the next couple of years, according to the Wall Street Journal. Reuters adds that that number represent about 12 percent of the company’s workforce. According to AstraZeneca, “these plans include a reduction in the number of disease area targets within our core therapeutic areas, a continued focus on externalisation, some consolidation of our activities onto a smaller R&D site footprint.”